SS Innovations International (NASDAQ: SSII) announced that its SSi Mantra surgical robotic system will be featured at the 2026 Society of Robotic Surgery Annual Meeting, taking place July 23-26 in Hollywood, Florida. The system will be displayed throughout the event, with multiple breakout sessions dedicated to it, including a live broadcast of a remote partial nephrectomy performed by Dr. Amitabh Singh from the company’s headquarters in Gurugram, India, on a patient at Rajeev Gandhi Cancer Institute and Research Centre in New Delhi.
The demonstration underscores the growing capabilities of telesurgery, a key focus for the industry. Chairman and CEO Dr. Sudhir Srivastava will participate as a speaker and panelist in sessions covering telesurgery, robotic surgery adoption, regulatory frameworks, and global access to robotic care. As of July 6, 2026, the SSi Mantra system has been used in 12,375 procedures spanning more than 170 procedure types, including 653 cardiac procedures, 178 telesurgeries, and 225 pediatric surgeries. Approximately 2,100 physicians have been trained on the platform.
For the healthcare industry, the SSi Mantra’s track record highlights the increasing adoption of robotic surgery, particularly in complex procedures like cardiac and pediatric surgeries. The system’s cost-effectiveness and user-friendly design aim to make robotic surgery more accessible globally, potentially reducing disparities in surgical care. For patients, this could mean greater access to minimally invasive procedures, which often result in shorter recovery times and fewer complications. The live telesurgery broadcast demonstrates the potential for remote surgical expertise to reach underserved areas, a crucial development for global health equity.
The Society of Robotic Surgery Annual Meeting is a key event for professionals in the field, and SS Innovations’ prominent role indicates the company’s growing influence. With over 12,000 procedures completed and a wide range of surgical types supported, the SSi Mantra system is positioned as a versatile tool in the robotic surgery landscape. The company’s focus on affordability and accessibility could drive further adoption, particularly in regions where high-cost robotic systems have been a barrier.
For investors, the announcement reinforces SS Innovations’ progress in commercializing its technology. The company, headquartered in India but incorporated in the U.S., continues to expand its global footprint. The full press release is available at https://ibn.fm/YYYKE. Forward-looking statements in the release caution that actual results may differ due to risks outlined in SEC filings, as detailed in the company’s most recent Annual Report on Form 10-K and other filings.
